Just one week after receiving US Food and Drug Administration approval to provide deep brain stimulation (DBS) surgery while patients are under general anesthesia, Medtronic plc announced the agency also has greenlighted new magnetic resonance imaging (MRI) labeling for its DBS systems.
Patients With Movement Disorders Will Benefit From Medtronic’s Expanded MRI Labeling For DBS
Medtronic announced it received expanded MRI labeling for its DBS systems, which is critical, given that almost 70% of all DBS-eligible patients will likely need an MRI at some point in their care, says Ashwini Sharan, CMO for Medtronic Neuromodulation.
